Influenza B virus B/Washington/02/2019 recombinant hemagglutinin antigen

DB15702ApprovedWithdrawnVaccines

A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen".

First approval
United States, 2020

Resolves to

What you can answer from here — as of September 01, 2026

19Clinical trialsPhase, status and sponsor resolved per trial
Sign in
9Marketed productsAcross 5 countries and 5 labellers
Sign in

Which companies are running trials of Influenza B virus B/Washington/02/2019 recombinant hemagglutinin antigen, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account